Cephalosporin VS Carbapenem for low risk AmpC organisms

OTHER2 trials

Sponsors

Sunnybrook Health Sciences Centre

Conditions

Gram-negative Bacteremia

Unknown Phase

BALANCE+ Vanguard Phase

CompletedNCT05893147

Sunnybrook Health Sciences CentreGram-negative Bacteremia

Start: 2023-08-26End: 2024-08-10Updated: 2024-10-01

A Platform Trial for Gram Negative Bloodstream Infections

RecruitingNCT06537609

Sunnybrook Health Sciences CentreGram-negative Bacteremia

Start: 2024-04-24End: 2028-04-01Target: 2500Updated: 2026-09-04

Related Papers

Towards use of Patient-informed Relevant Outcomes (PRO) in trials of bloodstream infections: a mixed-methods study protocol (BALANCE+PRO).

2026-07-02

Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE.

2025-12-05